Published by Josh White on 6th June 2025
(Sharecast News) - N4 Pharma reported a reduced operating loss of £1.22m for 2024 on Friday, down from £1.42m the prior year, as the biotech company continued to develop its proprietary Nuvec gene delivery platform.
URL: http://www.digitallook.com/dl/news/story/35133145/...